cmv vaccine

BIOLOGICAL2 trials

Sponsors

Hadassah Medical Organization, CMV Research Foundation

Conditions

CMV DiseaseCytomegalovirus

Phase 1

Adoptive Immunotherapy for CMV Disease

WithdrawnNCT00159055

Hadassah Medical OrganizationCMV Disease

Start: 2004-02-29Target: 20Updated: 2011-04-08

Safety Study of Four Chimera Cytomegalovirus (CMV) Vaccines in Healthy Adult Males 30-50 Years of Age

CompletedNCT01195571

CMV Research FoundationCytomegalovirus

Start: 2010-09-30End: 2014-10-31Updated: 2015-05-19

Related Papers

A Phase 1 Study of 4 Live, Recombinant Human Cytomegalovirus Towne/Toledo Chimera Vaccines in Cytomegalovirus–Seronegative Men

The Journal of Infectious Diseases2016-08-1155 citations